1-4 of 4
Jose Lutzky
Close
Sort by
Journal Articles

A Retrospective Study to Evaluate the Incidence and Severity of Peripheral Neuropathy for Relapsed/Refractory Multiple Myeloma Patients upon Retreatment with Bortezomib

James R. Berenson, MD, Jacob D. Bitran, MD, Imad Tabbara, MD FACP, Jose Lutzky, MD, Laura V. Stampleman, MD, Sikander Ailawadhi, MD, Ronald Steis, MD, Mehdi M. Moezi, MD
Journal: Blood
Blood (2014) 124 (21): 3469.
https://doi.org/10.1182/blood.V124.21.3469.3469
Published: 2014
Journal Articles

Long-Term Follow-Up of Patients Treated with Bortezomib Alone and in Combination with Dexamethasone as Frontline Therapy for Multiple Myeloma.

Sundar Jagannath, MD, Brian G.M. Durie, MD, Jeffrey Lee Wolf, MD, Elber S. Camacho, David Irwin, MD, Jose Lutzky, MD, Marti McKinley, BSN, Afshin Eli Gabayan, MD, Amitabha Mazumder, MD, John Crowley, PhD, Robert Vescio, MD
Journal: Blood
Blood (2006) 108 (11): 796.
https://doi.org/10.1182/blood.V108.11.796.796
Published: 2006
Journal Articles

A Multicenter Phase II Study of Combination Treatment with Melphalan, Arsenic Trioxide and Vitamin C (MAC) for Patients with Relapsed or Refractory Multiple Myeloma.

James Berenson, Ralph Boccia, David Siegel, Marek Bozdech, Alberto Bessudo, Edward Stadtmauer, J. Talisman Pomeroy, Ronald Steis, Marshall Flam, Jose Lutzky, Syed Jilani, Joseph Volk, Tiberio Lindgren, Robert Moss, Ravi Patel, Delina Ferreti, Howard Yeh, Sal Bevivino
Journal: Blood
Blood (2005) 106 (11): 2564.
https://doi.org/10.1182/blood.V106.11.2564.2564
Published: 2005
Journal Articles

A Phase 2 Study of Bortezomib as First-Line Therapy in Patients with Multiple Myeloma.

Sundar Jagannath, MD, Durie Brian, MD, Jeffrey L. Wolf, MD, Elber Camacho, MD, David Irwin, MD, Jose Lutzky, MD, Marti McKinley, MD, Eli Gabayan, MD, Amitabha Mazumder, MD, John Crowley, PhD, David Schenkein, MD
Journal: Blood
Blood (2004) 104 (11): 333.
https://doi.org/10.1182/blood.V104.11.333.333
Published: 2004